<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Fidelity Aberdeen Street Trust - Advisor Sustainable Target Date 2035 Fund — News on 6ix</title>
<link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1</link>
<description>Latest news and press releases for Fidelity Aberdeen Street Trust - Advisor Sustainable Target Date 2035 Fund on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1" rel="self" type="application/rss+xml" />
<item>
<title>Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting</title>
<link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/immutep-announces-abstract-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/immutep-announces-abstract-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>SYDNEY, AUSTRALIA, April 22, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy</description>
</item>
<item>
<title>The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform</title>
<link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/the-beauty-health-company-announces-corporate-rebrand-to-skinhealth-systems-reflecting-evolution-into-a-clinically-driven-science-backed-medical-aesthetics-platform-6</link>
<guid isPermaLink="true">https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/the-beauty-health-company-announces-corporate-rebrand-to-skinhealth-systems-reflecting-evolution-into-a-clinically-driven-science-backed-medical-aesthetics-platform-6</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>The Company will continue trading on the Nasdaq Capital Market under the ticker symbol “SKIN” LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- The</description>
</item>
<item>
<title>Best Buy Announces Chief Executive Officer Succession Plans</title>
<link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/best-buy-announces-chief-executive-officer-succession-plans-1</link>
<guid isPermaLink="true">https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2035-fund-1/news/best-buy-announces-chief-executive-officer-succession-plans-1</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>Jason Bonfig to succeed Corie Barry as Chief Executive Officer, following her planned departure at the end of Q3 MINNEAPOLIS--(BUSINESS WIRE)-- Best Buy Co.,</description>
</item>
</channel>
</rss>